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Abstract
Aims In Malaysia, Shigella spp. is the third most common
bacterial agent responsible for childhood diarrhoea. This
study was conducted to determine the prevalence and
antimicrobial susceptibility patterns of Shigella spp. isolat-
ed from patients admitted to the Hospital Universiti Sains
Malaysia from January 2001 to December 2009.
Subjects and methods A hospital-based retrospective study
was used. Stool samples from patients were cultured using
a standard culture method. Shigella spp. isolates were
identified by biochemical and serological methods, and the
antimicrobial susceptibility pattern was evaluated using the
Kirby-Bauer disc-diffusion method.
Results Atotalof138Shigella spp. were isolated from a total
of 14,830 routine stool specimens, yielding an isolation rate
of 0.93% that corresponded to 9.99% of the 1,381 bacterial
pathogens isolated. Of these isolates, S. sonnei was the
predominant species, followed by S. flexneri and S. boydii.
Seasonal variation was noticed, and no significant differences
were detected in the demographic data for S. flexneri and S.
sonnei. The susceptibility of all isolated Shigella strains was
tested against seven antibiotics. Ceftriaxone (99.1%), cipro-
floxacin (98.4%), and nalidixic acid (93.8%) were effective
against the Shigella strains, whereas tetracycline and
trimethoprim-sulfamethoxazole exhibited high frequencies
of resistance (58.4% and 53.8%, respectively).
Conclusion This study is important for public health
education aimed at reducing the morbidity and mortality
associated with Shigella spp. infection. Our results also will
be helpful for paediatricians and microbiologists in the
selection of appropriate antibiotics for the management of
diarrhoea.
Keywords Shigella.Prevalence.Antimicrobial
susceptibility.Diarrhoea
Introduction
Shigellosis, an intestinal infection caused by bacteria, is a
global human health problem. It is one of the major epidemic
diseases in the history of mankind, and it is one of the most
common killing diseases of children all over the world.
Shigellosis is the most important cause of bloody diarrhoea
worldwide, especially in underdeveloped and developing
nations with substandard hygiene and poor quality of water
supplies; it also affects travelers from industrialised countries
(Bennish and Wojtyniak 1991; Niyogi 2005). The four
species of Shigella differ epidemiologically. S. dysenteriae is
primarily associated with epidemics of serotype 1 and is
associated with the highest fatality rate (5–15%) (Ingersoll et
al. 2002). S. flexneri predominates in areas of endemic
infection and is the most frequently isolated species in
developing countries (Faruque et al. 2002;N i y o g ia n d
Pazhani 2003; Zafar et al. 2005), and S. sonnei has been
implicated in source outbreaks in developed countries (Katouli
et al. 1989;H a l ee ta l .1991;B o n f i g l i oe ta l .2002; Ekdaha
and Andersson 2005; Hamamoto et al. 2000). S. boydii is
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DOI 10.1007/s10389-010-0384-0associated with source outbreaks in Central and South
America and is rarely isolated in North America (Kalluri et
al. 2004). Kotloff et al. (1999) reported the percentage
distribution of S. flexneri, S. sonnei, S. boydii,a n dS.
dysenteriae to be 60%, 15%, 6%, and 6%, respectively, in
developing countries, and 16%, 77%, 2%, and 1%, respec-
tively, in developed countries. Outbreaks generally are
associated with contaminated water, food, overcrowded
communities, food handlers, and flies (Kapperud et al. 1995;
Shears 1996).
Shigella infection occurs by the faecal-oral route. The
minimum infective dose is extremely low; as few as 10–
100 bacilli can initiate the disease, as it can survive gastric
acidity better than other enterobacteria. The bacilli infect
the epithelial cells of the villi in the large intestine and
multiply inside them, spreading laterally to adjacent cells
and penetrating into the lamina propria (Warren et al.
2006). Shigella infection can lead to illness ranging from
mild, self-limited diarrhoea to severe dysentery with
frequent passage of blood and mucus, high fever, abdom-
inal pain, abdominal cramping, malaise, chills, nausea,
vomiting, tenesmus, and, in rare cases, bacteraemia.
Complications of shigellosis occur most frequently in
children, the elderly, and immunocompromised patients.
Prompt treatment with effective antimicrobial agents may
shorten the duration of clinical symptoms and reduce the
spread of infection (Replogle et al. 2000).
A definitive diagnosis of shigellosis can be made by
isolating the organism from a stool sample. Shigellosis is one
of the few enteric infections for which antimicrobials are
prescribed. Shigella species have managed to survive the
antibiotic era via an ingenious mechanism of resistance that
has complicated the selection of empirical agents for its
treatment (WHO 2001, 2005; Sivapalasingam et al. 2006;
Kansakar et al. 2007;K u oe ta l .2008; Djie-Maletz et al. 2008;
Sire et al. 2008). Moreover, antimicrobial resistance among
Shigella spp. varies from region to region (Bhattacharya et al.
2005; Pazhani et al. 2005; Taneja 2007). Thus, when
choosing an appropriate antibiotic to treat shigellosis, it is
important to understand the local antimicrobial resistance.
Herein, we report the prevalence of various Shigella species
as well as the local antibiotic susceptibility pattern in
Northeast Malaysia.
Materials and methods
Study design and subjects
A retrospective study was conducted by collecting data
from the Department of Medical Microbiology and Parasi-
tology, Hospital Universiti Sains Malaysia (HUSM),
Malaysia. The institute, an 800-bed tertiary-care teaching
hospital, provides low-cost medical care to the regional
population of the Northeastern region of Malaysia as well
as to the population of the border area of the neighboring
country, Thailand. Stool specimens were collected from
patients with clinically suspected dysentery who were
admitted to HUSM between January 2001 and December
2009. Most of these patients visited HUSM with complaints
of abdominal pain, vomiting, diarrhoea, and fever. Faecal
specimens were collected from patients of all age groups.
Demographic data such as age and sex, and the season
during which the illness occurred were collected by
questionnaire. These data were analysed using SPSS
version 12 (SPSS Inc., USA). The association among
Shigella spp., age, and sex was analysed using Fisher’s
exact test. The differences among the groups were
considered to be statistically significant at p<0.05.
Sample collection
During the study period, faecal samples were collected from
patients in a clean, wide-mouth, sterile container. Freshly
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Fig. 1 Distribution of Shigella
isolates (n=120) by age group
from HUSM from 2001–2009
232 J Public Health (2011) 19:231–236collected faecal specimens were transported within 2 h of
collection to the clinical laboratory for further processing.
Bacteriological examination
Stool specimens were plated on MacConkey and deoxy-
cholate citrate agar (DCA) using a sterile inoculation loop.
At the same time, another subsample was enriched in
selenite F broth and incubated overnight at 37°C. The next
day, enriched broth was subcultured on MacConkey agar
and DCA, and incubated overnight at 37°C. Colonies
morphologically resembling Shigella spp. were further
evaluated with biochemical tests using triple sugar iron
(TSI), urea agar slant, methyl red (MR), Simmon’s citrate
agar slant, and sulphur indole motility (SIM) media.
Colonies were serologically confirmed by slide agglutina-
tion with appropriate group-specific polyvalent antisera,
followed by type-specific monovalent antisera (Denka-
Seikan, Tokyo, Japan). Non-serotypable isolates were
further identified by API 20E (BioMerieux, France).
Drug susceptibility test
Antibiotic susceptibility of the Shigella isolates was tested
using the Kirby-Bauer disc-diffusion method on Muller-
Hinton agar plates following the guidelines of the Clinical
and Laboratory Standards Institute (CLSI 2005). An isolate
that is able to grow in the presence of an antibiotic in the
medium is considered to be resistant. Resistance or
sensitivity is defined according to the size of the zone of
inhibition around the discs, and it correlates with the
standard minimal inhibitory concentration (MIC), which is
the lowest concentration that visibly inhibits bacterial
growth. This correlation permits extrapolation from this
simple test to the more complicated agar or broth dilution
MIC test. A control strain of Escherichia coli (ATCC 25922)
was included in the test as a quality control. Commercially
manufactured discs (Oxoid, Hampshire, England) containing
antimicrobial agents were used, and their concentrations in
μg/ml were as follows: ampicillin-10 (AMP), ciprofloxacin-
5 (CIP), trimethoprim-sulphamethoxazole-25 (SXT), nali-
dixic acid-30 (NAL), chloramphenicol-30 (CHL),
ceftriaxone-30 (CRO), and tetracycline-30 (TCY). For
NAL, only data for the years 2001, 2002, and 2006–2009
were included.
Results
Bacteriological examination
During the 9-year study period, a total of 14,830 routine
stool samples were collected from patients with clinically
suspected dysentery, and laboratory examinations of these
samples were carried out to determine the prevalence of
Shigella isolates. A total of 138 Shigella-specific strains
were isolated from 1,381 isolates positive for bacterial
pathogens, which corresponded to 9.99% of the total
bacterial pathogens isolated. Shigella strains were isolated
from specimens from symptomatic patients of all age
groups. S. sonnei was the most prevalent isolate (n=69,
50.0%), followed by S. flexneri (n=68, 49.3%) and S.
S .flexneri S. sonnei P-value
Age group (n=120) Paediatrics n=33 (57.9%) n=33 (52.4%) 0.585
Adult n=24 (42.1%) n=30 (47.6%)
Gender (n=135) Male n=28 (41.8%) n=27 (39.7%) 0.862
Female n=39 (58.2%) n=41 (60.3%)
Table 1 Distribution of
Shigella isolates by age
group and gender
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J Public Health (2011) 19:231–236 233boydii (n=1, 0.7%). Eighty-six Shigella strains (61.8%)
were isolated from paediatric patients younger than 15 years
of age, and 42.0% of the total positive samples was
obtained from children ≤5 years old. Figure 1 shows the
distribution of Shigella isolates by age group in 5-year age
intervals. In this study, demographic data for S. flexneri and
S. sonnei were not significantly different (Table 1).
Seasonality and yearly distribution
In Malaysia, environmental conditions remain almost the
same throughout the year, with the exception of the rainy
season in November and December. Figure 2 shows that the
seasonal distribution of infection with Shigella spp.
Shigellosis occurred throughout the year, but was more
prevalent during the months of May to August, followed by
the rainy season.
Figure 3 shows the yearly distribution of the Shigella
isolates. S. flexneri was the most common species isolated
in 2001 (70.6%), 2002 (81.5%), and 2004 (60.0%). In
2003, a shift occurred, and S. sonnei replaced S. flexneri as
the most prevalent species. Subsequently, a gradual
decreasing trend for S. flexneri was observed until 2008.
In 2009, S. sonnei remained the dominant species, although
a few strains of S. flexneri were isolated.
Drug susceptibility
Figure 4 shows the results of the tests of antimicrobial
susceptibility of Shigella isolates against seven antimicro-
bial agents. The highest sensitivity was detected for CRO
(99.1%), followed by CIP (98.4%) and NAL (93.8%). High
sensitivity of Shigella isolates to CHL (68.0%) and AMP
(67.4%) also was detected. The most frequent antibiotic
resistance was observed for TCY and SXT, with resistance
rates of 58.4% and 53.8%, respectively. Resistance to one
or more drugs was observed in 100% of the 138 isolates.
The frequency of resistance for TCY, SXT, AMP, and CHL
was the highest compared to the other antibiotics.
A comparative analysis of the sensitivity of the Shigella
isolates against the individual antibiotics was performed.
The highest sensitivity of S. sonnei occurred with CRO
(98.4%), followed by CHL (96.9%), CIP (96.8%), AMP
(95.5%), and NAL (95.2%). The resistance percentage for
S. sonnei was greatest for TCY (52.7%), followed by SXT
(52.9%). S. flexneri was most sensitive to CIP (100%) and
CRO (100%), followed by NAL (96.2%). S. flexneri was
most resistant to TCY (73.3%), SXT (54.0%), CHL
(66.0%), and AMP (60.0%). S. boydii showed the highest
sensitivity to CIP, CRO, and NAL, and was resistant to the
remaining antimicrobial agents tested.
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Shigellosis is the most communicable of the bacterial
diarrhoeas. According to the WHO, an estimated 165
million episodes of shigellosis occur annually, resulting
in 1.1 million fatalities (Kotloff et al. 1999). Because
shigellosis is highly contagious, awareness of the
prevalence of the disease, the identity of the dominant
strain, and the antimicrobial susceptibility of the domi-
nant strain is crucial to ensuring proper clinical treatment
andpatientmanagement,andforepidemiologicalinvestigation
purposes.
Shigella spp. still accounts for a significant propor-
tion of bacillary dysentery in many tropical and
subtropical countries. In the Lee and Puthacheary
(2003) study of bacterial enteropathogens in a Malaysian
urban hospital, Shigella spp. were isolated from 1.4%
(386 isolates) of total stool specimens, corresponding to
13% of the 2,986 isolates positive for bacterial pathogens.
In our study the isolation rate was 0.93%, corresponding
to 9.99% of the 1,381 isolates positive for bacterial
pathogens. The possible underestimation of Shigella spp.
prevalence can result from both delayed transportation
and non-use of a transport medium. Over the course of the
9-year study, the isolation rate did not vary for S. sonnei
(50.0%) and S. flexneri (49.3%), and S. dysenteriae was
not detected at all.
The monthly distribution of Shigella spp. did not play
an important role in shigellosis prevalence. The infection
occurred throughout the year, with the highest isolation in
June followed by a second peak in November (i.e., two
peaks each year). In 2001, 2002, and 2004, S. flexneri was
the most common of the four species, whereas in 2003 and
from 2005 to 2009, S. sonnei was the dominant species.
This finding differs from those of studies conducted in
other developing countries (Faruque et al. 2002;N i y o g i
and Pazhani 2003; Zafar et al. 2005), where S. flexneri
was the most frequently isolated species; however, our
results match findings in developed countries (Katouli et
al. 1989;H a l ee ta l .1991;H a m a m o t oe ta l .2000;
Bonfiglio et al. 2002; Ekdaha and Andersson 2005).
In our study, Shigella spp. were isolated from stool
specimens of symptomatic patients of all age groups (from
<1 month to >85 years of age) seen in our hospital. Of
these, the majority of Shigella-specific strains were
obtained from paediatric patients younger than 15 years
of age, and the highest prevalence was seen in the ≤5 years
age group. This finding was in agreement with the results
of Lee and Puthacheary’s( 2002) study of patients with
diarrhoea admitted to the University of Malaya Medical
Centre (UMMC), Kuala Lumpur, Malaysia. Their study
showed that diarrhoea due to Shigella is a disease that
affects all ages, but that it is commonly seen in paediatric
patients. Other studies also have reported that the highest
prevalence of Shigella is seen in the ≤5 years age group
(Arya et al. 1977; Mutanda et al. 1979; MoezArdalan et
al. 2003).
Shigella spp. were most sensitive to the antibiotics
CRO, CIP, and NAL, and the sensitivity did not vary
much among species or strains; this finding is similar
to the results reported by Fulla et al. (2005). Resistance
to individual drugs varied among the three Shigella
species, and this was especially true for AMP and CHL.
All three Shigella species also exhibited a very high rate
of resistance to TCY and SXT. A similar pattern of
resistance has been reported in Pakistan, Turkey, India,
and Nepal (Ayser and Guriz 1998; Fulla et al. 2005;
Pazhani et al. 2005). We found significant differences in
the antimicrobial susceptibility of S. flexneri and S.
sonnei to AMP and CHL. Overall, S. flexneri was more
f r e q u e n t l yr e s i s t a n tt oT C Y ,S X T ,A M P ,a n dC H L ,a l o n e
or in combination, than was S. sonnei. A possible
explanation is that infections due to S. sonnei are
clinically less severe than infections due to the other
Shigella species, making exposure to selective pressure
from antibiotics less likely.
These results strongly suggest that TCYand SXT can no
longer be used to treat cases of severe diarrhoea and
dysentery at HUSM. Although our sample size may not
reflect the genuine spectrum of Shigella spp. in this part og
Malaysia, our results are significant: To our knowledge, this
study is the first to describe the prevalence of Shigella spp.
and their antimicrobial resistance patterns in Northeastern
Malaysia.
In conclusion, our study demonstrates that S. sonnei is
currently the predominant species at HUSM. The antimi-
crobial resistance pattern suggests widespread resistance of
Shigella to TCY and SXT. However, recommendations
about antimicrobial treatment must be updated regularly
based on surveillance results.
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